Addressing AI Bias in Medical Settings
Exploring the impact of AI bias in healthcare and solutions to ensure equitable patient care.
- Latest
- Trending
Exploring the impact of AI bias in healthcare and solutions to ensure equitable patient care.
Fortress Biotech reveals Q2 2024 financials with key FDA updates; NDA and BLA filings signal growth in dermatology and oncology.
Manufacturers enhance quality assurance and training using XR technology, bridging workforce skill gaps.
Lilly's new Boston facility enhances RNA/DNA research, hosting 500 scientists and expanding Gateway Labs to the East Coast.
PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
AI integration in biotech could reduce R&D costs, enhance efficiency, and increase returns for investors.
KULR Technology Group reports Q2 2024 financials, showing revenue shifts and strategic advancements.
Recursion Pharmaceuticals merges with Exscientia to revolutionize drug discovery, bringing new treatments to market more quickly.
Legend Biotech reports significant revenue growth in Q2 2024, with strategic advancements in CAR-T therapies.
Huawei's smart string ESS passes tech appraisal, showing innovation in renewable energy integration and grid stability.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.